Metastatic melanoma: prognostic factors and survival in patients with brain metastases

Brain metastases from malignant melanoma carry a poor prognosis. Novel systemic agents have improved overall survival (OS), but the value of whole-brain radiotherapy (WBRT) and stereotactic radiosurgery (SRS) remains uncertain. The melanoma-specific graded prognostic assessment (msGPA) provides usef...

Descripción completa

Detalles Bibliográficos
Autores principales: Frinton, E., Tong, D., Tan, J., Read, G., Kumar, V., Kennedy, S., Lim, C., Board, R. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700221/
https://www.ncbi.nlm.nih.gov/pubmed/28819707
http://dx.doi.org/10.1007/s11060-017-2591-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700221/
https://www.ncbi.nlm.nih.gov/pubmed/28819707
http://dx.doi.org/10.1007/s11060-017-2591-9

Ejemplares similares